Agios Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights
Agios Pharmaceuticals, Inc. share price today is $37.08, up 0.22%. The stock opened at $36.59 against the previous close of $36.28, with an intraday high of $36.59 and low of $35.62.
Agios Pharmaceuticals, Inc. Share Price Chart
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Share Price Performance
Agios Pharmaceuticals, Inc. Institutional Holdings
Agios Pharmaceuticals, Inc. Market Status
Agios Pharmaceuticals, Inc. Fundamentals
Market Cap 2157.63 M
PB Ratio 0.8822
PE Ratio 0.0
Enterprise Value 2047.29 M
Total Assets 1297.23 M
Volume 890110
Agios Pharmaceuticals, Inc. Company Financials
About Agios Pharmaceuticals, Inc. & investment objective
Company Information Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 539
Industry Biotechnology
CEO Mr. Brian M. Goff M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Agios Pharmaceuticals, Inc. FAQs
What is the share price of Agios Pharmaceuticals, Inc. today?
The current share price of Agios Pharmaceuticals, Inc. is $37.08.
Can I buy Agios Pharmaceuticals, Inc. shares in India?
Yes, Indian investors can buy Agios Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Agios Pharmaceuticals, Inc. shares in India?
You can easily invest in Agios Pharmaceuticals, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Agios Pharmaceuticals, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Agios Pharmaceuticals, Inc..
Can I buy fractional shares of Agios Pharmaceuticals, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. has a market cap of $2157.63 M.
In which sector does Agios Pharmaceuticals, Inc. belong?
Agios Pharmaceuticals, Inc. operates in the Biotechnology sector.
What documents are required to invest in Agios Pharmaceuticals, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Agios Pharmaceuticals, Inc.?
The PE ratio of Agios Pharmaceuticals, Inc. is N/A and the PB ratio is 0.88.